🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several experts said the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Reaction and Material Removal

According to TikTok, the platform has removed violative material and banned associated keywords and query recommendations. The organization said it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, glowing testimonials and detailed guides for mixing or injecting at home.

After minutes of joining one community, a seller shared contact information, where most purchases occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these communities, posts display dark colored packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to potentially serious health risks”.